This is a snippet of the transcript, sign up to read more.
From a product standpoint, I think an area where Keyence lacks is in providing a full solution. Cognex and other competitors have done a great job of developing a machine building network or a full turnkey solution network. You buy the camera and sensors from them, and they put it all together on a conveyance system. In contrast, Keyence only offers the components and doesn't have as strong a network in that aspect as other companies. When I was on the strategic account team, my focus was also on machine builders. They're trying to develop that network, but it's challenging to penetrate that market.
This is a snippet of the transcript, sign up to read more.
Research and Development, 100%. Keyence, bar none, spends more money, time, and energy on developing new products. They often have products that are first to market. For instance, their clamp-on flow meters were an industry first, allowing flow readings without cutting into a pipe. Their vision systems were also first to market, mastering the art of pattern projection. They excel in strobing, structuring a light source on a product, and capturing three-dimensional data with cameras. They've mastered timing of lighting and cameras, and ultrasonic sensing, which takes competitors a long time to figure out. By the time competitors catch up, Keyence is already onto the next innovation.
This is a snippet of the transcript, sign up to read more.
Interestingly, there isn't a significant decay. For example, Keyence came out with the new VS Vision system. Some niche applications don't need the VS; they might need a controller-based vision system with four cameras. The price doesn't really decay on the older stuff. Products tend to phase out, especially with large customers willing to discount more. In terms of decay rate, older technology still has use and purpose.
This is a snippet of the transcript, sign up to read more.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2025 IP 1 Ltd. All rights reserved.
Subscribe to access hundreds of interviews and primary research